首页> 外国专利> BIOMATERIAL FOR PREVENTION OF POSTOPERATIVE COMMISSURES INCLUDING HYALURONIC ACID (VERSIONS) AND METHOD OF PREVENTING POSTOPERATIVE TISSUE COMMISSURES

BIOMATERIAL FOR PREVENTION OF POSTOPERATIVE COMMISSURES INCLUDING HYALURONIC ACID (VERSIONS) AND METHOD OF PREVENTING POSTOPERATIVE TISSUE COMMISSURES

机译:预防包括透明质酸(版本)的术后并发症的生物材料和预防术后组织委员会的方法

摘要

FIELD: surgery. SUBSTANCE: biomaterial, in particular hyaluronic acid benzyl ester, in which 75 to 100% of hyaluronic acid carboxyl groups are substituted. Up to 25% of carboxyl groups can be substituted via esterification by C10-C20- aliphatic alcohol, provided that at least 80% of carboxyl groups are esterified. Biomaterial is made in the form of membrane, gauze, woven or nonwoven web or gel. Optional biomaterial contains at least one hyaluronic acid derivative, which is auto-cross-linked derivative wherein 0.5 to 20% of hyaluronic acid carboxyl groups are cross-linked hydroxyl groups of the same or another hyaluronic acid molecule. Postoperative commissures are prevented by applying above-described biomaterial onto tissue involved into surgical operation. EFFECT: created commissure formation barrier until healing completion to avoid such problems as infection, calcification of implants, formation of scar, etc. 12 cl, 10 dwg, 9 tbl, 18 ex
机译:领域:手术。物质:生物材料,特别是透明质酸苄基酯,其中75至100%的透明质酸羧基被取代。前提是至少80%的羧基被酯化,最多25%的羧基可以通过C10-C20-脂族醇进行酯化取代。生物材料以膜,纱布,织造或非织造纤维网或凝胶的形式制成。任选的生物材料包含至少一种透明质酸衍生物,其是自交联的衍生物,其中0.5至20%的透明质酸羧基是相同或另一个透明质酸分子的交联的羟基。通过将上述生物材料施加到涉及外科手术的组织上来防止术后合缝。效果:创建连合形成屏障,直到愈合完成,以避免感染,植入物钙化,疤痕形成等问题。12 cl,10 dwg,9 tbl,18 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号